BioLineRx Enrolls First Patient in Phase 2 Clinical Trial

BioLineRx Enrolls First Patient in Phase 2 Clinical Trial for BKT-140/BL-8040, for Treatment of Leukemia Partial results expected in Q4 2013. Read More